PDSB Latest Press Releases

-- October 20, 2026 --

PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors Globe Newswire 8:00 AM

-- October 6, 2026 --

PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases Globe Newswire 8:00 AM

-- September 22, 2026 --

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology Globe Newswire 8:00 AM

-- September 14, 2026 --

PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors Globe Newswire 10:30 AM

-- September 8, 2026 --

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks Globe Newswire 8:30 AM

-- August 13, 2026 --

PDS Biotech Reports Second Quarter 2026 Financial Results Globe Newswire 8:30 AM

-- August 11, 2026 --

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101 Globe Newswire 8:25 AM

Market Data Delayed 15 Minutes